Recursion Pharmaceuticals, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
VANGUARD GROUP INC | 08/11/2025 | 36.07 M | $182.52 M | 11.72% | 8.64% |
ARK INVESTMENT MANAGEMENT LLC | 07/30/2025 | 32.99 M | $166.92 M | -5.25% | 7.90% |
BLACKROCK, INC. | 08/12/2025 | 28.37 M | $143.56 M | 20.69% | 6.80% |
BAILLIE GIFFORD & CO | 08/06/2025 | 24.17 M | $122.32 M | -0.90% | 5.79% |
SOFTBANK GROUP CORP. | 08/14/2025 | 14.67 M | $74.22 M | 0.00% | 3.51% |
KINNEVIK AB (PUBL) | 08/13/2025 | 13.43 M | $67.98 M | 0.00% | 3.22% |
MUBADALA INVESTMENT CO PJSC | 08/14/2025 | 12.99 M | $65.71 M | 0.00% | 3.11% |
STATE STREET CORP | 08/14/2025 | 11.18 M | $56.57 M | -14.56% | 2.68% |
NOVO HOLDINGS A/S | 08/14/2025 | 9.67 M | $48.91 M | 0.00% | 2.32% |
MIC CAPITAL MANAGEMENT UK LLP | 08/14/2025 | 9.64 M | $48.80 M | 0.00% | 2.31% |
SUMITOMO MITSUI TRUST HOLDINGS, INC. | 07/31/2025 | 8.17 M | $41.33 M | -3.67% | 1.96% |
NIKKO ASSET MANAGEMENT AMERICAS, INC. | 08/11/2025 | 8.17 M | $41.25 M | -2.85% | 1.96% |
GEODE CAPITAL MANAGEMENT, LLC | 08/08/2025 | 7.78 M | $39.35 M | 20.68% | 1.86% |
NVIDIA CORP | 08/14/2025 | 7.71 M | $38.99 M | 0.00% | 1.85% |
DATA COLLECTIVE IV GP, LLC | 08/14/2025 | 5.94 M | $30.06 M | 0.00% | 1.42% |
MORGAN STANLEY | 08/15/2025 | 5.69 M | $28.79 M | 13.56% | 1.36% |
FMR LLC | 08/14/2025 | 5.58 M | $28.26 M | -18.43% | 1.34% |
UBS GROUP AG | 08/14/2025 | 4.63 M | $23.43 M | -16.86% | 1.11% |
UBS ASSET MANAGEMENT AMERICAS INC | 08/14/2025 | 4.62 M | $23.35 M | -27.98% | 1.11% |
DCVC OPPORTUNITY FUND II GP, LLC | 08/14/2025 | 3.95 M | $19.99 M | 0.00% | 0.95% |
EXOR CAPITAL LLP | 08/13/2025 | 3.68 M | $18.60 M | 0.00% | 0.88% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2025 | 3.21 M | $16.22 M | 56.39% | 0.77% |
NORGES BANK | 08/13/2025 | 3.17 M | $16.04 M | 100.00% | 0.76% |
NORTHERN TRUST CORP | 08/13/2025 | 2.91 M | $14.75 M | 21.70% | 0.70% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2025 | 2.59 M | $13.10 M | 13.64% | 0.62% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2025 | 2.37 M | $11.99 M | 66.52% | 0.57% |
FIRST TRUST ADVISORS LP | 08/13/2025 | 1.88 M | $9.51 M | 82.29% | 0.45% |
CITADEL ADVISORS LLC | 08/14/2025 | 1.72 M | $8.68 M | 361.44% | 0.41% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2025 | 1.66 M | $8.42 M | 42.90% | 0.40% |
PEAK6 LLC | 08/14/2025 | 1.45 M | $7.33 M | 1,937.69% | 0.35% |
BANK OF AMERICA CORP /DE/ | 08/14/2025 | 1.38 M | $6.98 M | 7.31% | 0.33% |
VESTMARK ADVISORY SOLUTIONS, INC. | 08/06/2025 | 1.34 M | $6.78 M | 89.62% | 0.32% |
CITADEL ADVISORS LLC | 08/14/2025 | 1.31 M | $6.65 M | -50.50% | 0.32% |
NUVEEN, LLC | 08/12/2025 | 1.23 M | $6.20 M | -35.92% | 0.29% |
TWO SIGMA INVESTMENTS, LP | 08/14/2025 | 1.17 M | $5.91 M | 1.32% | 0.28% |
BARCLAYS PLC | 08/14/2025 | 1.16 M | $5.89 M | 97.07% | 0.28% |
CAPTION MANAGEMENT, LLC | 08/14/2025 | 1.15 M | $5.83 M | 100.00% | 0.28% |
JUMP FINANCIAL, LLC | 08/13/2025 | 1.15 M | $5.83 M | 94.34% | 0.28% |
GOLDMAN SACHS GROUP INC | 08/14/2025 | 1.13 M | $5.72 M | -24.38% | 0.27% |
BANK OF NEW YORK MELLON CORP | 08/05/2025 | 1.08 M | $5.47 M | 25.25% | 0.26% |
COMPREHENSIVE FINANCIAL MANAGEMENT LLC | 08/12/2025 | 941.90 K | $4.77 M | 0.00% | 0.23% |
IQ EQ FUND MANAGEMENT (IRELAND) LTD | 08/01/2025 | 911.09 K | $4.61 M | 135.28% | 0.22% |
MILLENNIUM MANAGEMENT LLC | 08/14/2025 | 739.41 K | $3.74 M | 47.26% | 0.18% |
CAPITAL FUND MANAGEMENT S.A. | 08/13/2025 | 720.53 K | $3.65 M | 247.63% | 0.17% |
LIONTRUST INVESTMENT PARTNERS LLP | 08/19/2025 | 702.39 K | $3.55 M | 18.04% | 0.17% |
CITADEL ADVISORS LLC | 08/14/2025 | 698.95 K | $3.54 M | -48.60% | 0.17% |
DIADEMA PARTNERS LP | 08/14/2025 | 698.40 K | $3.53 M | 0.00% | 0.17% |
NAN FUNG GROUP HOLDINGS LTD | 08/13/2025 | 664.61 K | $3.36 M | 0.00% | 0.16% |
D. E. SHAW & CO., INC. | 08/14/2025 | 633.40 K | $3.21 M | 939.97% | 0.15% |
XTX TOPCO LTD | 08/12/2025 | 631.21 K | $3.19 M | 100.00% | 0.15% |
Recursion Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 411 institutional investors and hedge funds held shares of Recursion Pharmaceuticals, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 36.07 M
ARK Investment Management LLC: 32.99 M
BlackRock, Inc.: 28.37 M
BAILLIE GIFFORD & CO: 24.17 M
SOFTBANK GROUP CORP.: 14.67 M
Kinnevik AB (publ): 13.43 M
74.32% of Recursion Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 338.02 M shares in the last 24 months. This purchase volume represents approximately $2.06 B in transactions.